ExpressPoints: Caring for Patients Treated With Immune Checkpoint Inhibitors

Download this short summary slideset of clinical highlights for nurses and pharmacists caring for patients receiving immune checkpoint inhibitors today.
Stephanie Andrews, MS, ANP-BC
Marianne Davies, DNP, CNS, ACNP-BC, AOCNP
John Thompson Headshot
John A. Thompson, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 446 KB
Released: June 26, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bristol-Myers Squibb
Merck Sharp & Dohme Corp.

Related Content

In slides from Clinical Care Options (CCO), experts provide insights on the optimal use of immune checkpoint inhibitors for HCC and BTCs

R. Kate Kelley, MD Amit G. Singal, MD, MS Released: January 27, 2021

From Clinical Care Options, download slides reviewing the integration of CAR T-cell therapy into community care

Michael R. Bishop, MD Jae H. Park, MD Released: January 26, 2021

Gain key clinical insights quickly with this short slideset from Clinical Care Options (CCO) on the integration of CAR T-cell therapy into community care

Michael R. Bishop, MD Jae H. Park, MD Released: January 26, 2021

Asim V. Farooq, MD, and colleagues answer FAQs from a live CCO Webinar audience on ocular toxicity in patients receiving ADCs for multiple myeloma

Asim V. Farooq, MD
Program Director
Sagar Lonial, MD Anthony Perissinotti, PharmD, BCOP
Released: January 25, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue